Cell Transplantation, 2015 Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder caused by mutations in the dystrophin gene. Adipose-derived stem cells (ASCs) are an attractive source of cells for stem cell therapy.
Eun-Mi Lee +8 more
doaj +1 more source
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department [PDF]
, 2020 As of March 30th, 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise.
Brown, Cortlyn +2 more
core
H29 Comparison of the efficacy of two angiotensin II antagonists, valsartan and losartan, in essential hypertension [PDF]
, 1997 Pascale Oddou-Stock
openalex +1 more source
A case of losartan induced angioedema
Indian Journal of Medical Sciences, 2010 Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) target the renin-angiotensin system and are used in the management of hypertension. Both classes of drugs have similar side effects. ARBs are considered to be much better tolerated than ACE inhibitors with lesser incidence of side effects.
openaire +3 more sources
Dataset on the degradation of losartan by TiO2-photocatalysis and UVC/persulfate processes
Data in Brief, 2020 Losartan is a highly consumed antihypertensive worldwide and commonly found in effluents of municipal wastewater treatment plants. In the environment, losartan can promote harmful effects on organisms.
John F. Guateque-Londoño +4 more
doaj
Cell Transplantation, 2012 Recently, adipose tissue-derived stem cells (ASCs) were emerged as an alternative, abundant, and easily accessible source of stem cell therapy. Previous studies revealed losartan (an angiotensin II type I receptor blocker) treatment promoted the healing ...
Jin-Kyu Park +11 more
doaj +1 more source
Cost-Effectiveness of Losartan Versus Atenolol in Treating Hypertension—An Analysis of the LIFE Study from a Swiss Perspective [PDF]
, 2018 Aims: To determine the economic benefit of losartan versus atenolol in patients with essential hypertension from the perspective of the Swiss healthcare system.
Burnier, Michel +2 more
core
A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients A placebo-controlled, forced titration study [PDF]
, 1999 Yves Lacourcière
openalex +1 more source
Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study [PDF]
, 1999 P Di Pasquale +5 more
openalex +1 more source
Revista de Medicina de la Universidad de Navarra, 2017 E G, Quetglas +3 more
openaire +2 more sources